By G HossainPosted on November 18, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Only one clinical-stage asset from the ProfoundBio acquisition remains in development: The antibody-drug conjugate Rina-S, in late-stage studies for ovarian and endometrial cancer. Genmab Prunes Another ADC From $1.8B ProfoundBio Acquisition Post navigation Nxera’s Quest for Profitability Claims 15% of WorkforceTIGTA makes plans for IRS investigations next year